SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Jasmin Loh, Ian D Davis, Jarad M Martin, Shankar Siva, Extracranial oligometastatic renal cell carcinoma: current management and future directions, Future Oncology, 2014, 10, 5, 761

    CrossRef

  2. 2
    Fang Huang, Gang Wu, Kunyu Yang, Oligometastasis and oligo-recurrence: more than a mirage, Radiation Oncology, 2014, 9, 1, 230

    CrossRef

  3. 3
    O. Riesterer, M. Guckenberger, Stereotaktische Strahlentherapie von Metastasen, Der Onkologe, 2014, 20, 8, 757

    CrossRef

  4. 4
    David A. Palma, Joseph K. Salama, Simon S. Lo, Suresh Senan, Tom Treasure, Ramaswamy Govindan, Ralph Weichselbaum, The oligometastatic state—separating truth from wishful thinking, Nature Reviews Clinical Oncology, 2014, 11, 9, 549

    CrossRef

  5. 5
    Fang Hu, Ronald B. Gartenhaus, Xianfeng F. Zhao, Hong-Bin Fang, Samuel Minkove, Daniella E. Poss, Aaron P. Rapoport, c-Myc and E2F1 drive PBK/TOPK expression in high-grade malignant lymphomas, Leukemia Research, 2013, 37, 4, 447

    CrossRef

  6. 6
    Lorenzo Tosco, Hendrik Van Poppel, Bruno Frea, Steven Joniau, Reply from Authors re: Francesco Greco. Metastatic Renal Cell Carcinoma: An Invincible Enemy? Eur Urol 2013;63:653–4, European Urology, 2013, 63, 4, 655

    CrossRef

  7. 7
    Wenting Li, Rui Wang, Linfu Bai, Zhangming Yan, Zhirong Sun, Cancer core modules identification through genomic and transcriptomic changes correlation detection at network level, BMC Systems Biology, 2012, 6, 1, 64

    CrossRef

  8. 8
    Daniela Wuttig, Stefan Zastrow, Susanne Füssel, Marieta I. Toma, Matthias Meinhardt, Kristin Kalman, Kerstin Junker, Jimsgene Sanjmyatav, Kerstin Boll, Jörg Hackermüller, Axel Rolle, Marc-Oliver Grimm, Manfred P. Wirth, CD31, EDNRB and TSPAN7 are promising prognostic markers in clear-cell renal cell carcinoma revealed by genome-wide expression analyses of primary tumors and metastases, International Journal of Cancer, 2012, 131, 5
  9. 9
    Julien Edeline, Stéphanie Mottier, Cécile Vigneau, Florence Jouan, Christophe Perrin, Selim Zerrouki, Patricia Fergelot, Jean-Jacques Patard, Nathalie Rioux-Leclercq, Description of 2 angiogenic phenotypes in clear cell renal cell carcinoma, Human Pathology, 2012, 43, 11, 1982

    CrossRef

  10. 10
    Heba W. Z. Khella, Nicole M. A. White, Hala Faragalla, Manal Gabril, Mina Boazak, David Dorian, Bishoy Khalil, Hany Antonios, Tian Tian Bao, Maria D. Pasic, R. John Honey, Robert Stewart, Kenneth T. Pace, Georg A. Bjarnason, Michael A. S. Jewett, George M. Yousef, Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses, Tumor Biology, 2012, 33, 1, 131

    CrossRef

  11. 11
    Xi-Liang Cao, Jiang-Ping Gao, Wei Wang, Yong Xu, Huai-Yin Shi, Xu Zhang, Expression of Pituitary Tumor Transforming Gene 1 is an Independent Factor of Poor Prognosis in Localized or Locally Advanced Prostate Cancer Cases Receiving Hormone Therapy, Asian Pacific Journal of Cancer Prevention, 2012, 13, 7, 3083

    CrossRef

  12. 12
    A. Rose Brannon, Scott M. Haake, Kathryn E. Hacker, Raj S. Pruthi, Eric M. Wallen, Matthew E. Nielsen, W. Kimryn Rathmell, Meta-analysis of Clear Cell Renal Cell Carcinoma Gene Expression Defines a Variant Subgroup and Identifies Gender Influences on Tumor Biology, European Urology, 2012, 61, 2, 258

    CrossRef

  13. 13
    Lui Shiong Lee, Min-Han Tan, Predictive models for the practical management of renal cell carcinoma, Nature Reviews Urology, 2012, 9, 2, 73

    CrossRef

  14. 14
    Gianni Sava, Gérard Jaouen, Elizabeth A. Hillard, Alberta Bergamo, Targeted therapy vs. DNA-adduct formation-guided design: thoughts about the future of metal-based anticancer drugs, Dalton Transactions, 2012, 41, 27, 8226

    CrossRef

  15. 15
    J. Thariat, S. Vignot, R.-J. Bensadoun, F. Mornex, Traitement locaux ablatifs de la maladie oligométastatique : les progrès technologiques modifient les profils évolutifs cliniques, Cancer/Radiothérapie, 2012, 16, 5-6, 325

    CrossRef

  16. 16
    Egbert Oosterwijk, W. Kimryn Rathmell, Kerstin Junker, A. Rose Brannon, Frédéric Pouliot, David S. Finley, Peter F.A. Mulders, Ziya Kirkali, Hirotsugo Uemura, Arie Belldegrun, Basic Research in Kidney Cancer, European Urology, 2011, 60, 4, 622

    CrossRef

  17. 17
    D. Moro-Sibilot, O. Pop, M.-V. Albahary, A.-C. Toffart, La maladie oligométastatique dans les cancers bronchiques non à petites cellules, Revue des Maladies Respiratoires Actualités, 2011, 3, 4, 406

    CrossRef

  18. 18
    Ralph R. Weichselbaum, Samuel Hellman, Oligometastases revisited, Nature Reviews Clinical Oncology, 2011,

    CrossRef

  19. 19
    Ik Yong Kim, Factors Affecting the Outcome of a Pulmonary Resection for Metastatic Colorectal Cancer: Efficacy and Pitfalls, Journal of the Korean Society of Coloproctology, 2010, 26, 5, 309

    CrossRef

  20. 20
    Joachim Pfannschmidt, Hans Hoffmann, Hendrick Dienemann, Reported Outcome Factors for Pulmonary Resection in Metastatic Colorectal Cancer, Journal of Thoracic Oncology, 2010, 5, S172

    CrossRef